# A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors

Source: https://onco.cc/trials/nct07028281/  
OnCo record `nct07028281` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Adebrelimab, Carboplatin, Cisplatin and SHR-8068 in advanced solid tumours, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., now recruiting.

## Summary

A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors is a phase 2 interventional study registered as NCT07028281 by Suzhou Suncadia Biopharmaceuticals Co., Ltd., with 120 participants planned, started 2025-07-08 and due to reach its primary completion in 2028-12. Interventions recorded: SHR-4849、SHR-1316、SHR-8068、BP102、carboplatin、cisplatin.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07028281
- Phase: 2
- Setting: A Multicenter, Open-label, Phase II Clinical Study of SHR-4849 Injection Combined With Other Antineoplastic Drugs in Patients With Malignant Solid Tumors
- Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Enrolled: 120

## Sources

- ClinicalTrials.gov NCT07028281: https://clinicaltrials.gov/study/NCT07028281

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [SHR-8068](https://onco.cc/drugs/shr-8068/)
- companies: [Jiangsu Hengrui Pharmaceuticals](https://onco.cc/companies/hengrui/)

---
JSON: https://onco.cc/api/v1/entities/nct07028281.json